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INTRODUCTION
The National Institutes of Health Patient-Reported Out-
comes Measurement Information System (PROMIS; trade-
marked by the National Institutes of Health) Roadmap
initiative (available at www.nihpromis.org) is a coopera-
tive research program designed to develop, evaluate, and
standardize item banks to measure patient-reported out-
comes across different medical conditions as well as the
US population (1). The goal of PROMIS is to develop
reliable and valid item banks using item response theory
(IRT) that can be administered in a variety of formats
including short forms and computerized adaptive tests
(CAT) (1–3). IRT is often referred to as “modern psycho-
metric theory,” in contrast to “classic test theory,” or CTT.
The basic idea behind both IRT and CTT is that there is
some latent construct, or “trait,” underlying an illness
experience. This construct cannot be directly measured,
but can be indirectly measured by creating items that are
scaled and scored. For example, fatigue, pain, disability, or
even “happiness” are latent constructs, i.e., subjective feel-
ings—we cannot take a picture, snap a radiograph to view
them, or run a blood test to check for them. However, we
know they exist. People can experience more or less of
these constructs; therefore, it is helpful to try to translate
that experience into several levels represented by scores.
IRT models the associations between items and the latent
construct. Speciﬁcally, IRT models describe relationships
between a respondent’s underlying level on a construct
and the probability of particular item responses.
Tests developed with CTT (such as the Health Assess-
ment Questionnaire disability index [HAQ DI] [4], or the
Scleroderma Gastrointestinal Tract instrument [5]) require
administering all items, even though only some are appro-
priate for the person’s trait level. Some items are too high
for those with low trait levels (e.g., “can you walk 100
yards” to a patient in a wheelchair) or too low for those
with high trait levels (e.g., “can you get up from the chair?”
to a runner). In contrast, IRT methods make it possible to
estimate person trait levels with any subset of items ap-
propriate for the person’s trait levels in an item pool. As
such, any set of items from the pool could be administered
as a ﬁxed form or, for greatest efﬁciency, administered as a
CAT. CAT is an approach to administering the subset of
items in an item bank that are most informative for mea-
suring the health construct in order to achieve a target
standard error of measurement. A good item bank will
have items that represent a range of content and difﬁculty,
provide high levels of information, and have items that
perform equivalently in different subgroups of the target
population.
HOW DOES CAT WORK?
Without prior information, the ﬁrst item administered in a
CAT is typically one of medium trait level. For example,
“In the past 7 days I was grouchy” with multilevel re-
sponses ranging from “never” to “always.” After each re-
sponse, the person’s trait level and associated standard
error are estimated. The next item administered to some-
one not endorsing the ﬁrst item is an easier item. If the
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person endorses the ﬁrst item, the next item administered
is a harder item. CAT is terminated when the standard
error falls below an acceptable value. This provides an
estimate of one’s score with the minimal number of ques-
tions and no loss of measurement precision. In addition,
scores from different studies using different items can be
compared using a common scale. IRT models estimate the
underlying scale score (theta) from the items. All items are
calibrated on the same metric and independently and col-
lectively provide an estimate of theta. Hence, it is possible
to estimate the score using any subset of items and to
estimate the standard error of the estimated score. This
allows assessment of health outcomes across patients with
differing medical conditions (such as comparing scores of
someone with arthritis to someone with heart disease) at
various degrees of physical and other impairments, both at
the lowest and highest ends of trait levels.
PROMIS IN RHEUMATOLOGY
The Life Story of PROMIS Tools
Since the beginning of PROMIS in 2004, much progress
has been made in developing measures of self-reported
health within a domain hierarchy (Figure 1). Physical
functioning, fatigue, pain, emotional distress, and social
health were the core domains of interest. While all these
domains are relevant to rheumatic diseases, the physical
health domain encompassed most of the traditionally im-
portant outcomes in rheumatology, such as physical func-
tion, pain, and fatigue.
In PROMIS, the term physical function was preferred
over the term disability and represented the ability to
perform activities of daily living including instrumental
activities (e.g., shopping) (6). The PROMIS physical func-
tion item bank containing 124 new items was developed
from 1,865 available items culled from 160 English lan-
guage questionnaires. In addition to administering the
item bank using CAT, PROMIS has developed several
static short forms including: 1) a 20-item PROMIS HAQ,
which corresponds to the HAQ DI, 2) a PROMIS 10-item
static, or short form with items selected as the “best” from
the physical function items, and 3) a PROMIS 20-item
static form also selected from the “best” PROMIS items.
PROMIS HAQ differs from the HAQ DI by deleting the
1-week time frame and increasing the response option set
from the original 4 choices to 5 by adding “with a little
difﬁculty.” Measurement properties of different PROMIS
item banks (PROMIS HAQ, PROMIS 10-item short form,
PROMIS 20-item short form, and 10-item PROMIS CAT)
were compared to the HAQ DI and physical functioning
10-item scale (PF-10) of the Short Form 36 in 378 patients
with rheumatoid arthritis, osteoarthritis, and normal aging
cohorts (7). PF-10 provided the least content information
followed by HAQ DI, which was better for patients with
physical disability (SD less than or equal to 1) but per-
formed poorly for the average population (Figure 2).
PROMIS items (10 or 20 items) performed better than
PF-10 and HAQ DI. The PROMIS CAT outperformed all
the static items (Figure 2). The CAT maintained acceptable
performance in populations whose physical function is
1.5 SDs better than the population norm. This has impli-
cations for our patients because as better treatments be-
come available for rheumatic diseases we are likely to
observe healthier cohorts of patients with arthritis. Thus,
accurate assessment of those in the positive health range of
physical functioning becomes increasingly important.
What PROMIS Means for Rheumatology
Physical function, global health assessment, and fatigue
are important constructs in rheumatic diseases, in both
adults and pediatrics. The availability of PROMIS tools
will also catalyze research on the less well-studied impact
of rheumatic diseases in all health domains. In the next
sections, we discuss the advantages of PROMIS, its current
use in rheumatology, and the future of PROMIS in rheu-
matology.
Advantages of PROMIS over traditional instruments.
PROMIS employes a uniform qualitative process with de-
tailed systematic review, focus groups, cognitive inter-
views, and translatability for each item bank. PROMIS has
devoted substantive resources to ensuring that outcome
measures are understood and usable by diverse popula-
tions. Items are written at a grade school level and tested
for comprehensibility among low-literacy populations. All
items are reviewed and modiﬁed as needed for their trans-
latability. To enhance inclusiveness, PROMIS informatics
assessment tools are rendered accessible to populations
with sensory limitations and others requiring assistive
technology. Lastly, PROMIS measures are grounded in a
life course perspective, as it is the group’s ultimate goal to
produce single metrics for the same domain across the full
lifespan (i.e., PROMIS is linking measures developed for
children with those developed for adults).
PROMIS instruments have been found to have better
precision than existing measures; a quality that may lead
to reduction in sample size in clinical studies (6). The
severity of patient-reported outcomes in rheumatic dis-
eases can be compared head-to-head with other chronic
conditions such as heart failure. It is possible to “custom-
ize” the set of items by selecting a set of items that is
matched to the severity level of the target population.
Figure 1. Patient-Reported Outcomes Measurement Information
System (PROMIS) domain hierarchy. Color ﬁgure can be viewed
in the online issue, which is available at http://onlinelibrary.
wiley.com/journal/10.1002/(ISSN)1529-0131.
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PROMIS items are currently available at no cost, enabling
freer exchange of information and data, stimulating out-
comes research.
Utilization of CAT to administer PROMIS items does
require a computer, and that may limit its applicability in
a busy clinical practice. Although a person may receive
different set of items from an item pool at each visit, users
can track which items were administered in the CAT and
track theta scores over time.
Current PROMIS item banks and their validation in
rheumatology. PROMIS item banks for adult patients.
PROMIS item banks developed for adults (including anger,
anxiety, abilities and general concern, depression, fatigue,
pain behavior, pain interference, physical function, posi-
tive and negative psychosocial impact of illness, sleep
disturbance, sleep impairment, satisfaction with participa-
tion in social roles, and satisfaction with participation in
discretionary social activities) are available at www.
nihpromis.org. Additional short forms have been devel-
oped for constructs such as global health, global satisfac-
tion with sex life, etc. All these item banks measure
important constructs that are applicable to patients with
arthritis and other rheumatologic conditions. As an exam-
ple, the feasibility of 11 PROMIS item banks was recently
assessed in a single-center, observational study in patients
with systemic sclerosis (8). The average number of items
completed for each CAT-administered item bank ranged
from 5 to 8 (69 CAT items per patient), and the average
time to complete each CAT-administered item bank
ranged from 48 seconds to 1.9 minutes per patient (average
time 11.9 minutes/per patient for 11 banks). The time to
complete the item banks was not signiﬁcantly different in
patients with physical disabilities (such as hand contrac-
tures and digital ulcers).
PROMIS item banks for pediatric patients. PROMIS
version 1.0 item banks and short forms developed for
children include anger, anxiety, asthma impact, depres-
sive symptoms, fatigue, pain interference, physical func-
tion (separate banks for upper extremity and mobility), and
peer relationships and are available at www.nihpromis.org.
The PROMIS Cooperative Network is currently in the pro-
cess of evaluating the pediatric version 1.0 item banks in
multiple pediatric chronic conditions including juvenile
idiopathic arthritis (JIA) and chronic musculoskeletal
pain, widespread or regional. Importantly, the process in-
cludes a qualitative component including semistructured
interviews with children. Longitudinal validation in these
pediatric conditions, among others, is underway.
New PROMIS item banks under development. The
PROMIS Cooperative Network has increased the focus and
energy on development of pediatric item banks with 4 of
12 of the PROMIS II sites (project period 2009–2012) ded-
icated to work in pediatrics. This includes development of
new pediatric item banks to assess pain behavior, pain
quality, physical activity, subjective well-being, experi-
ence of stress and others, all of which are important in
patients with chronic arthritis. Current efforts are also
focused on linking adult and pediatric item banks measur-
ing the same construct to allow measurement from child-
hood through adolescence then transition to adulthood on
the same metric. The PROMIS Cooperative Network is also
developing new item banks pertinent to chronic diseases.
These include development of gastrointestinal symptoms
items, self-efﬁcacy for self-management of chronic illness,
and others.
Future of PROMIS in rheumatology. The PROMIS mis-
sion is to use measurement science to create a state-of-the-
art assessment system for self-reported health to advance
Figure 2. Comparison of information content of 6 physical function instruments: Health
Assessment Questionnaire disability index (HAQ DI), Patient-Reported Outcomes Measure-
ment Information System (PROMIS) HAQ, PROMIS 10-item short form, PROMIS 20-item
short form, physical functioning 10-item score (PF-10; from Short Form 36), and 10-item
PROMIS computer (CAT). Instruments with greater information content have SE curves that
are lower and have a greater SD range at a reliability0.95. More items are better than fewer,
item response theory (IRT)-based (PROMIS) is better than non–IRT-based items, and CAT is
better than static. Adapted with permission from ref. 7.
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patent-reported outcome measurement in clinical research
and day-to-day practice. Similar to other patient-reported
outcomes, this will facilitate the incorporation of the pa-
tient’s voice into clinical trials and clinical practice. The
American College of Rheumatology has endorsed the as-
sessment of functional status in patients with rheumatoid
arthritis at least every 12 months. For patients with JIA, it
is recommended that functional status and health-related
quality of life be assessed at 6 month intervals (9). This
exacts new requirements of patient-reported outcome mea-
sures, including exceptional ease of use, rapidity of ad-
ministration, interpretability, and a clear beneﬁt of using
the data in patient-provider interactions and care manage-
ment. Rheumatology is a specialty that is well versed in
the use of measures of disability, pain, and other aspects of
health-related quality of life. PROMIS offers an opportu-
nity to accelerate uptake and expand the use of patient-
reported outcomes from research advocates to all clini-
cians.
Using PROMIS in Clinical Practice
Being able to administer a choice of fatigue, pain interfer-
ence, physical function, or depression measures, among
many other options, in the waiting room on a Tablet,
laptop, personal computer, and potentially a Smart Phone
and have instant scoring, calibration to population norms,
and be ready to share with the patient at point of care is
compelling.
As an example, Figures 3 and 4 show results from a
50-year-old patient with early diffuse systemic sclerosis.
This patient was administered CAT item banks for physi-
cal function and depression that took approximately 2
minutes to complete. The proﬁle provides his current
physical function (1.7 SDs below US general population)
and depression status (2 SDs below US population). This
information (presented in the form of a PROMIS report in
Figure 3 and a graph as shown in Figure 4) can be used for
clinical care. This patient was referred for psychological
counseling to help him adjust to his newly diagnosed
systemic sclerosis and also prescribed physical therapy.
The item banks can be administered at each clinic visit to
assess change in symptoms from baseline visit. Current
work is ongoing to assess the feasibility of incorporating
PROMIS item banks in routine clinical practice.
In conclusion, PROMIS has developed items banks that
are relevant to rheumatology, can be “customized” to a
patient or a practice, and are currently freely available.
The item banks provide tremendous ﬂexibility for creation
of ﬁxed length short forms or CAT administration. This
quick assessment can generate a patient report to monitor
health over time.
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Figure 3. Computer generated Patient-Reported Outcomes Mea-
surement Information System (PROMIS) report of a 50-year-old
man with recently diagnosed systemic sclerosis. The report pro-
vides the patient’s scores for depression and physical function
scales and compares it to the US general population.
Figure 4. Computer-generated Patient-Reported Outcomes Mea-
surement Information System (PROMIS) graph of a 50-year-old
man with recently diagnosed systemic sclerosis. The report de-
picts the patient’s score for depression and physical function
scales and compares it to the US general population. Color ﬁg-
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